Priority Date: 29.09.14 (US 201462057030P)

METHODS OF TREATING MUCOPOLYSACCHARIDOSIS IIIB (MPSIIIB)

  • Application ID: EP15847215
  • Status: Request for examination was made

Attorney

no operation time available
Headquarter in London and 5 offices
active in Legal Services and Matchmaking and Trading

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Mathys & Squire LLP is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 174 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 29.09.2014 - Priority Date (US 201462057030P)
  • 07.04.2016 - Publication A1 (WO2016054025)
  • 09.08.2017 - Publication A1 (EP3200816)

IPC Classification